Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Eisai

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Eisai's 2012 sales performance.

Eisai Co., Ltd.

New survival data for Merck, Eisai’s Keytruda/Lenvima combination shows promise in kidney cancer

New survival data for Merck, Eisai’s Keytruda/Lenvima combination shows promise in kidney cancer

New data for Merck &Co (MSD) and Eisai’s Keytruda plus Lenvima combination treatment has demonstrated further promise for the therapy in advanced renal cell carcinoma (RCC) – the most common form ... In addition to the positive results for the

Merck, Eisai’s Keytruda plus Lenvima combo hits the mark in renal cancer

Merck, Eisai’s Keytruda plus Lenvima combo hits the mark in renal cancer Combination treatment topped Pfizer's Sutent in phase 3. Merck &Co/MSD and Eisai’s Keytruda plus Lenvima combination has scored positive top-line results from a phase 3 trial in ... According to Merck and Eisai, when administered alongside Lenvima,

FDA briefing documents back Biogen’s Alzheimer’s drug aducanumab

FDA briefing documents back Biogen’s Alzheimer’s drug aducanumab Biogen initially scrapped the Eisai-partnered drug in phase 3, on advice from an independent data committee.

Biogen, Eisai take Alzheimer’s candidate BAN2401 into phase 3

Biogen, Eisai take Alzheimer’s candidate BAN2401 into phase 3 Pivotal AHEAD 3-45 programme initiated this week. Biogen and Eisai, in collaboration with BioArctic and the Alzheimer’s Clinical Trials Consortium (ACTC), have announced the initiation of a phase 3 ... Biogen and Eisai are also currently studying

Biogen completes filing for highly-anticipated Alzheimer’s drug

Biogen completes filing for highly-anticipated Alzheimer’s drug It’s been a rocky road for Biogen’s aducanumab – following disappointing results in March last year, Biogen and partner Eisai said they were pulling the plug on the phase 3

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

How nature can help you manage the pressures of agency life
Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....